hydralazine hydrochloride

Generic: hydralazine hydrochloride

Labeler: remedyrepack inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name hydralazine hydrochloride
Generic Name hydralazine hydrochloride
Labeler remedyrepack inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

hydralazine hydrochloride 25 mg/1

Manufacturer
REMEDYREPACK INC.

Identifiers & Regulatory

Product NDC 70518-3852
Product ID 70518-3852_3f8c1a73-dd59-1bdc-e063-6294a90a54fc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA205236
Listing Expiration 2026-12-31
Marketing Start 2023-09-03

Pharmacologic Class

Classes
arteriolar vasodilation [pe] arteriolar vasodilator [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 705183852
Hyphenated Format 70518-3852

Supplemental Identifiers

RxCUI
905225
UNII
FD171B778Y

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name hydralazine hydrochloride (source: ndc)
Generic Name hydralazine hydrochloride (source: ndc)
Application Number ANDA205236 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BLISTER PACK (70518-3852-0)
source: ndc

Packages (1)

Ingredients (1)

hydralazine hydrochloride (25 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3f8c1a73-dd59-1bdc-e063-6294a90a54fc", "openfda": {"unii": ["FD171B778Y"], "rxcui": ["905225"], "spl_set_id": ["0d65e146-83e5-427f-ac06-04c0d8e72cea"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BLISTER PACK (70518-3852-0)", "package_ndc": "70518-3852-0", "marketing_start_date": "20230903"}], "brand_name": "Hydralazine Hydrochloride", "product_id": "70518-3852_3f8c1a73-dd59-1bdc-e063-6294a90a54fc", "dosage_form": "TABLET", "pharm_class": ["Arteriolar Vasodilation [PE]", "Arteriolar Vasodilator [EPC]"], "product_ndc": "70518-3852", "generic_name": "Hydralazine Hydrochloride", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Hydralazine Hydrochloride", "active_ingredients": [{"name": "HYDRALAZINE HYDROCHLORIDE", "strength": "25 mg/1"}], "application_number": "ANDA205236", "marketing_category": "ANDA", "marketing_start_date": "20230903", "listing_expiration_date": "20261231"}